WBA250117P30000
- 17.75
- 0.000.00%
Walgreens Boots Alliance Newsroom
Walgreens Boots Alliance Is Maintained at Sector Perform by RBC Capital
Walgreens Boots Alliance Analyst Ratings
RBC Capital Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating, Raises Target Price to $12
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Quanterix (QTRX) and Walgreens Boots Alliance (WBA)
A Quick Look at Today's Ratings for Walgreens Boots Alliance(WBA.US), With a Forecast Between $7 to $15
Jefferies Adjusts Walgreens Boots Alliance Price Target to $11 From $9
TD Cowen Adjusts Price Target on Walgreens Boots Alliance to $15 From $14
Evercore ISI Group Maintains In-Line on Walgreens Boots Alliance, Raises Price Target to $12
Walgreens Boots Alliance Is Maintained at Underperform by B of A Securities
Walgreens Boots Alliance Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Walgreens Boots Alliance (WBA)
BofA Securities Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Raises Target Price to $8.5
Challenges in Profitability and Financial Flexibility Lead to Sell Rating on Walgreens Boots Alliance
Morgan Stanley Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Raises Target Price to $15
Morgan Stanley Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Evercore Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating, Cuts Target Price to $12
Evercore ISI Raises Price Target on Walgreens Boots Alliance to $12 From $9
Morgan Stanley Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Maintains Target Price $7
Challenges and Uncertainties Lead to Sell Rating for Walgreens Boots Alliance